교수 및 연구

리서치하이라이트
리서치하이라이트

Network-based machine learning approach to predict immunotherapy respo…

첨부파일
  • 첨부된 파일이 없습니다.
  • 저널명Nat Commun. 2022 Jun 28;13(1):3703. doi: 10.1038/s41467-022-31535-6.
    • 담당교수Sanguk Kim
    • 조회294
    • 작성자최고관리자
    • 2022-06-30

    본문

    ■ Abstract

    Immune checkpoint inhibitors (ICIs) have substantially improved the survival of cancer patients over the past several years. However, only a minority of patients respond to ICI treatment (~30% in solid tumors), and current ICI-response-associated biomarkers often fail to predict the ICI treatment response. Here, we present a machine learning (ML) framework that leverages network-based analyses to identify ICI treatment biomarkers (NetBio) that can make robust predictions. We curate more than 700 ICI-treated patient samples with clinical outcomes and transcriptomic data, and observe that NetBio-based predictions accurately predict ICI treatment responses in three different cancer types-melanoma, gastric cancer, and bladder cancer. Moreover, the NetBio-based prediction is superior to predictions based on other conventional ICI treatment biomarkers, such as ICI targets or tumor microenvironment-associated markers. This work presents a network-based method to effectively select immunotherapy-response-associated biomarkers that can make robust ML-based predictions for precision oncology.

     

    f8277c5e838475986c4996cf97712163_1656555366_985.png